Illumina Inc
(NAS:ILMN)
$
146.17
-1.45 (-0.98%)
Market Cap: 23.18 Bil
Enterprise Value: 25.15 Bil
PE Ratio: 0
PB Ratio: 10.87
GF Score: 80/100 Illumina Inc at Piper Sandler Healthcare Conference Transcript
Nov 30, 2022 / 02:00PM GMT
Release Date Price:
$211.98
(+4.56%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
All right. Thank you, everybody, for coming. Thank you, Illumina, for coming.
Questions & Answers
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
I'm just going to start off with some of the weakness in the stock yesterday. Some of the things I heard from investors was -- number one, some of the 5% reduction in workforce, if that came before or after -- or you knew about that before or after when you gave long-range guidance or and even guidance for next year. And then number 2 is on the debt rate. So you've talked about some of the refi and some of the dynamics around the refinancing and kick it off that way.
Francis A. deSouza
Illumina, Inc. - CEO & Director
Yes. So look, our expectations on the long-range forecast that we gave or expectations that we gave have not changed, right? So we do expect that NGS and its ability to change how biology
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot